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The Heart Failure Overweight/Obesity
Survival Paradox
The Missing Sex Link
Amanda R. Vest, MBBS, Yuping Wu, PHD, Rory Hachamovitch, MD, MSC, James B. Young, MD, 
Leslie Cho, MD
O besity is a key determinant of cardiovascu-lar health and an independent risk factorfor the development of heart failure (HF)
(1,2). The “overweight” and “obese” states are
deﬁned by body mass index (BMI), with overweight-
ness diagnosed in the BMI range $25 to <30 kg/m2
and obesity $30 kg/m2. Among 59,178 adults followed
for a mean of 18 years, the adjusted hazard ratios for
incident HF at BMIs <25, 25 to 29.9, and $30 kg/m2
were 1.00, 1.25, and 1.99 (p < 0.001) for men and
1.00, 1.33, and 2.06 (p < 0.001) for women, respec-
tively (3). However, multiple investigators have
demonstrated an “obesity survival paradox” in HF
with reduced (and preserved) ejection fraction,
whereby overweight and obese patients have either
no increased mortality risk compared with normal
weight counterparts, or even a lower mortality risk
(4–10). Several potential explanations have been
postulated to explain these unexpected
survival outcomes, including the potential
confounding of cigarette smoking or undiag-
nosed systemic illness. There is also the pos-
sibility of “lead time bias” whereby obese
individuals present with HF symptoms
earlier in their disease course, or a “healthy
survivor effect,” whereby the most comorbid
obese individuals die before developing HF,
leaving the surviving obese HF patients
with disproportionately favorable outcomes.
The paradox could alternatively be explained
by the protection from cardiac cachexia
afforded by baseline excess adiposity or by
myocardial effects of adipokines secreted
from adipose tissue. Both the biological
mechanisms of the proposed paradoxical
relationship between BMI and mortality in
HF, and the role of sex in this relationship,
remain incompletely understood. Given the
female survival advantage in HF (11–13), and
the recognition that female myocardium
shows greater fatty acid metabolism and
lower glucose utilization (14), we hypothe-
sized that females with HF may derive a
greater degree of protection from excess
adiposity than males.
METHODS
STUDY POPULATION. We identiﬁed 4,380
consecutive adult patients with systolic HF
who underwent cardiopulmonary exercise
testing at Cleveland Clinic between January 1,
1995, and November 1, 2011. Institutional
review board approval was granted both for
the prospective recording of exercise testing data and
the retrospective collection of additional data speciﬁc
to this project; the requirement for informed consent
was waived. We removed 253 patients from the cohort
because of incomplete data, with either a missing
stress test date (n 4), missing mortality follow-up
data (n 46), no information in the electronic medi-
cal record to verify clinical data (n 116), or missing
key cardiopulmonary stress test parameters (n 87).
Patients with a baseline left ventricular ejection frac-
tion (LVEF) in the 41% to 50% range were removed
(n 130) to restrict analysis to individuals with
LVEF#40%.We ﬁltered out patients who had received
a heart transplant (n 15) or left ventricular assist
device (LVAD) (n 8) before their stress test date.
Patients with a primary valvular cardiomyopathy
etiology (n 85) or severe congenital heart disease
(n 27) were also excluded from this analysis. We also
excluded 51 patients with a BMI<18.5 kg/m2 (below the
“normal weight” range). Thus, the ﬁnal cohort con-
tained 3,811 subjects. If a patient underwent multiple
cardiopulmonary stress tests, only the initial test was
considered.
Baseline characteristics were prospectively recor-
ded in the stress test database by the exercise phys-
iologist conducting the test. Parameters such as HF
etiology, presence of coronary artery disease (CAD),
diabetes status, smoking status, and HF medications
were ascertained by the physiologist through a com-
bination of verbal history-taking and medical chart
review. The patient’s weight was always measured on
the day of the test. Smoking and medication status
were documented as current at the time of the test.
The presence of CAD was deﬁned as a prior myocar-
dial infarction or any degree of obstruction on coro-
nary imaging. Retrospective chart review was
performed for >20% of database subjects to conﬁrm
the accuracy of the prospectively entered data.
CARDIOPULMONARY EXERCISE TESTING. Symptom-
limited exercise stress testing was conducted by
trained exercise physiologists and supervised by a
physician. Exercise testing was performed using a
treadmill stress in the majority of patients; the alter-
nate option was a stationary bike. The exercise physi-
ologist assigned the patient to the Bruce, modiﬁed
Bruce, Cornell 0%, Cornell 5%, Cornell 10%, Naughton,
or modiﬁed Naughton protocols, appropriate to the
patient’s physical abilities. Gas exchange data were
collected throughout the test using a MedGraphics
cardiopulmonary metabolic cart (St. Paul, Minnesota).
Heart rate targets were not used as an endpoint or to
judge the adequacy of the test. Blood pressure was
manually measured every minute and the heart rate
was recorded from an electrocardiogram printed each
minute during the test. Electrocardiographic changes
and symptoms were also recorded at the end of each
stage. Heart rate recovery (HRR) was calculated as
peak exercise heart rate minus the heart rate at 1
minute post-exercise. A standard walking cool-down
was used during recovery.
The oxygen consumption (VO2) was averaged over
30-s intervals throughout the test and the peak VO2
was determined as the highest 30-s interval in the last
2 min of the test. The ventilatory threshold was
deﬁned as the VO2 at which expired carbon dioxide
increased nonlinearly relative to VO2 (V-slope
method). The ratio of the increase in ventilation to the
increase in CO2 output (VCO2) was recorded at peak
exercise (15). Estimated functional capacity was
ABBR EV I A T I ON S
AND ACRONYMS
ACE = angiotensin-converting
enzyme
AF = atrial ﬁbrillation
ARB = angiotensin receptor
blocker
BMI = body mass index
CAD = coronary artery disease
CI = conﬁdence interval
CRF = cardiorespiratory ﬁtness
HF = heart failure
HR = hazard ratio
HRR = heart rate recovery
HTN = hypertension
LBM = lean body mass
LVAD = left ventricular assist
device
LVEF = left ventricular ejection
fraction
MET = metabolic equivalent of
task
NW = normal weight (18.5 to
24.99 kg/m2)
NYHA = New York Heart
Association
OB = obese (‡30 kg/m2)
OW = overweight (25 to 29.99
kg/m2)
RER = respiratory exchange
ratio
SBP = systolic blood pressure
VE/VCO2 = ratio of ventilation
to increase in carbon dioxide
output
VO2 = oxygen uptake
Vt = tidal volume





mortality and 9% decrease in 1-year mortality per
5 kg/m2 BMI increase, p < 0.05 (24). No interaction
between sex and BMI was detected, with a hazard
ratio for all-cause mortality per 5 kg/m2 BMI of 0.87
(0.79 to 0.96) in males and 0.92 (0.85 to 0.99) in fe-
males, p for interaction 0.92. However, unlike our
study, the follow-up period was short, there was no
risk adjustment for cardiorespiratory ﬁtness (CRF),
and the relationship between BMI and mortality was
found to be log-linear.
It is notable that the unadjusted HRs in this analysis
suggested an obesity survival paradox in both males
and females, but that this disappeared with risk
adjustment. This highlights the critical importance of
careful covariate selection when constructing a model
that aims to determine the “pure” effect of baseline
BMI on subsequent outcomes. As demonstrated by
Güder and colleagues, adjustment by incrementally
more complete models can attenuate the strength of
the inverse relationship between BMI and mortality
(25). Measures of CRF have been also been shown
to attenuate the obesity paradox, in cohorts with
and without HF (26–30). There is a danger that
adding a wide range of potential confounders may
unknowingly insert a factor on the biological pathway
between BMI and mortality and negate a true
relationship. That the OW females continued to show a
signiﬁcantly lower adjusted HR makes this explana-
tion unlikely. The absence of an overall-adjusted HF
obesity survival paradox in this study is not unique
(8,29). It may be relevant to note that these prior
studies reporting no survival advantage for obese HF
patients had some similarities to our current study in
terms of their younger HF populations and risks ad-
justments for CRF.
The contribution of this sex-BMI analysis to the
study of the obesity paradox is 3-fold. First, this
analysis highlights the importance of recognizing a
nonlinear relationship between BMI and mortality to
permit detection of the differential effects of BMI on
survival within different regions of the BMI spec-
trum. We propose that the linearity of the BMI-
mortality relationship should always be examined
and more complex nonlinear modeling options pur-
sued if indicated. Second, it highlights the impor-
tance of adequate covariate adjustment given that
the 6 sex/BMI subgroups were quite dissimilar in
their baseline characteristics and an apparent
obesity paradox was replaced by a more nuanced
relationship between BMI and survival after covari-
ate adjustment. Third, the observation of a HF sur-
vival paradox that is limited to overweight females
FIGURE 2 Interaction Plot Between BMI and Sex for Nonischemic Etiology and Ischemic Etiology
(A) Nonischemic etiology; (B) ischemic etiology. Model adjusted for age, race, left ventricular ejection fraction, etiology, New York Heart
Association, digoxin, angiotensin converting enzyme inhibitor/angiotensin receptor blocker, beta blocker, diabetes, smoking, hypertension,
hyperlipidemia, atrial ﬁbrillation, rest systolic blood pressure, heart rate recovery, peak oxygen uptake, respiratory exchange rate, peak tidal
volume, heart transplantation, or left ventricular assist device placement. The nonparallel lines conﬁrm a differing relationship between BMI as
a continuous value (x axis) and adjusted mortality HR (y axis) in females versus males. For females, the lowest mortality hazard was seen just
below BMI 30 kg/m2, with higher HRs in the NW (<25 kg/m2) and stage II/III obesity (>35 kg/m2) regions of the x axis. Males had a higher
mortality hazard overall and showed an increased mortality hazard in the OW and OB ranges as compared with the NW range. BMI body mass
index; NW normal weight; OW overweight.
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